Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC4985288/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC4985288/. The analysis below is for the second page.

Title[redir]:
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes - PMC
Description:
The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. In this double-blind trial, we randomly assigned patients with type 2 diabetes and high ...

Matching Content Categories {📚}

  • Health & Fitness
  • Insurance
  • Social Networks

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🚀🌠 Tremendous Traffic: 10M - 20M visitors per month


Based on our best estimate, this website will receive around 10,538,143 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We're unsure if the website is profiting.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Ncbi.nlm.nih.gov could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

liraglutide, group, patients, cardiovascular, trial, doi, placebo, diabetes, outcome, events, primary, type, google, scholar, outcomes, nonfatal, supplementary, pubmed, novo, nordisk, death, appendix, ratio, rate, disease, data, lower, adverse, table, composite, hazard, risk, analysis, support, heart, pancreatitis, months, level, event, astrazeneca, myocardial, infarction, stroke, receiving, fees, randomization, fewer, acute, analyses, baseline,

Topics {✒️}

cox proportional-hazards model thyroid c-cell tumors continuous renal-replacement therapy onset persistent macro-albuminuria pmc copyright notice peptide-1 receptor agonists glp-1–receptor agonist lixisenatide pmc beta search cardiovascular risk-factor management independent event-adjudication committee glp-1–receptor agonists bristol-myers squibb–astrazeneca randomized placebo-controlled trials c-cell proliferation license information pmcid medullary thyroid carcinoma med abstract background c-cell hyperplasia bristol-myers squibb medullary thyroid cancer glycated hemoglobin level supplementary materials included plasma glucose level expanded composite outcome global expert panel nat rev nephrol adverse drug reactions receiving consulting fees trial-site staff event-adjudication committee united states government left ventricular hypertrophy unstable angina pectoris kaplan–meier method clinically meaningful interaction obvious single explanation taking standard therapy van de werf calcitonin levels acute coronary syndrome leader steering committee steering committee consisting peripheral vascular disease atherosclerotic vascular disease serum creatinine level lowering glucose levels full text presence versus absence left ventricular systolic glucose-lowering drugs

Questions {❓}

  • Is there a link between liraglutide and pancreatitis?
  • The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

External Links {🔗}(65)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • Foundation
  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.33s.